Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,991 stories, page 429 of 684

Advanced search

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Aurobindo Pharma Enters Non-Exclusive License Agreement With MSD

SahiOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech AG (NASDAQ: VRXA) Appoints Christoph Erkel as Chief Scientific Officer

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Chugai Pharmaceutical (CHGCF) Reports Strong First Half Earnings

GuruFocusOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Industry and D.C. Are Racing Ahead on Psychedelics. They Should Let Science Lead.

psychologytoday.comOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

African pharma giants secure deal for Merck’s monthly HIV pill

Channel AfricaOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Slides as Investors Digest a Post-Earnings Surge

Quiver QuantitativeOriginal source

🇺🇰Jul 25Researchsphr.nihr.ac.ukTier 2 · Direct publisher

Reflections from my PhD: Improving the mental health of young people through early intervention and prevention

NIHR School for Public Health ResearchOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Aurobindo Pharma inks HIV drug licensing deal with MSD for 129 countries

WhalesbookOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

StockStoryOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

FDA cracks down on food safety, suspends 6 eateries and bakeries in Mumbai

India.ComOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Chugai Pharmaceutical : Strong H1 FY 2026 growth with robust sales, high filings, and pipeline advances, including AQUA07 Fast Track

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Ipsen’s Bylvay Fails Phase 3 BOLD Trial In Rare Pediatric Liver Disease

londoninsider.co.ukOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

New treatment approach improves survival, reduces recurrence risk in muscle-invasive bladder cancer

Medical XpressOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

FDA advisers endorse legal path for peptides

PoliticoOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Boston Globe: Biotech is back, baby! A wave of life science deals is pumping cash into the sector.

Massachusetts Biotechnology CouncilOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Declaration of Voting Results by ApicHope Pharmaceutical

marketscreener.comOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

TradingViewOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

The Globe and MailOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Shanghai Xiao Fang Pharmaceutical Co., Ltd. Class A Revenue Breakdown – SSE:603207

TradingViewOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Why Geopolitical Supply Chain Mapping Is Critical for Life Sciences

Pharmaceutical CommerceOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

What Just Happened with Larimar Therapeutics (LRMR) and Why Does it Matter

Kavout | AIOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

America Is About to Go Over a Peptide Cliff

The AtlanticOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

FDA Advisory Committee Meetings: How They Work And Why Biotech Stocks Move

RTTNewsOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Here's Why You Should Add Cencora Stock to Your Portfolio Now

TradingViewOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Weekly Buzz: AZN, GSK JNJ Approvals; CUV Layoff, REGN, HALO, Samsun Deals, LLY, CLDX Data

RTTNewsOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

Another setback for Ipsen's Albireo portfolio as Bylvay flunks phase 3 trial

Fierce PharmaOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

FDA SIDE EFFECTS UPDATE: Low Blood Sugar Warning for Xeljanz, Rinvoq, and other JAK Inhibitors

MedShadow FoundationOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

Amgen hands in data package in hopes of FDA hearing for Tavneos defense

Fierce PharmaOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Antibody-drug conjugates reported in Bioray Pharmaceutical patent

BioWorld NewsOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Chia Tai Tianqing Pharmaceutical discovers new GIPR antagonists

BioWorld NewsOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Zonsen Peplib Biotech discloses new GPC3-targeting peptide-drug conjugates

BioWorld NewsOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

The Option Play Of The Week (NYSE:YSS)

Seeking AlphaOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

Sanofi’s $1.4B Kymab bet falters again as atopic dermatitis trials scrapped

BioSpaceOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

Adult epilepsy market to reach $17.bn across 7MM by 2035

Pharmaceutical TechnologyOriginal source

🇺🇰Jul 24Regulatorygov.ukTier 1 · Regulatory source

Meningococcal B (MenB) time limited vaccination offer: eligibility flow chart

Guidance for health professionals delivering the time-limited MenB vaccination offer on the eligible...

UK Health Security AgencyOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical (BMRN) On FDA Acceptance For VOXZOGO And The Valuation Case

simplywall.stOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

This Little-Known Biotech Stock Just Hit a New 5-Year High

Barchart.comOriginal source

🇪🇺Jul 24Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Safer Therapeutics Through Early Toxicity Detection

CORDISOriginal source

🇪🇺Jul 24Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Revolutionizing AML Therapy - A First-in-Class CK1 Inhibitor for Relapsed Refractory Patients

CORDISOriginal source

🇪🇺Jul 24Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Modeling oncogenesis, phenotypic identity and fate in brain cancer avatars

CORDISOriginal source

🇪🇺Jul 24Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Enzymatic STEreospecific RNA phosphorothioate modification for next-generation therapeutics

CORDISOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments

HealthDayOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

FDA warning letters highlight contamination control and facility maintenance failures

European Pharmaceutical ReviewOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

Jubilant Biosys Brings Together Global Biotech Leaders to Advance the Future of Healthcare Innovation at 2nd EDGE Innovation Forum

BioSpaceOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Merck expands access to alimatravir, generic drug for HIV treatment, to low- and middle-income countries

PharmaLiveOriginal source

🇫🇷Jul 24Regulatoryleem.orgTier 1 · Regulatory source

République démocratique du Congo : 8 tonnes de médicaments acheminées en Ituri pour soutenir la réponse à l'épidémie d'Ebola

LEEM FranceOriginal source

🌍Jul 24Regulatoryzamra.co.zmTier 1 · Regulatory source

WHO good manufacturing practices for pharmaceutical products: Main principles

Zambia Medicines Regulatory Authority (ZAMRA)Original source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Legend Biotech: Why I'm Ready To Go Long Again (NASDAQ:LEGN)

Seeking AlphaOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

Fatal gene-editing trial in China raises ethics and oversight questions

STATOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

GSK’s first lung cancer approval, a new IPO path and more

Fierce PharmaOriginal source

🌍Jul 24discoverynews.google.comTier 2 · Trade media

Fatal gene-editing trial in China raises ethics and oversight questions

STATOriginal source

🌍Jul 24Regulatoryzamra.co.zmTier 1 · Regulatory source

Guidelines on Goods Manufacturing Practices(WHO)

Zambia Medicines Regulatory Authority (ZAMRA)Original source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

US FDA peptide decision could create marketing challenges for beauty industry

Personal Care InsightsOriginal source

🌍Jul 24Regulatoryzamra.co.zmTier 1 · Regulatory source

Guidelines on Goods Manufacturing Practices

Zambia Medicines Regulatory Authority (ZAMRA)Original source

🌍Jul 24Regulatoryzamra.co.zmTier 1 · Regulatory source

SI-No-57-of-2017-Importation-and-Exportation

Zambia Medicines Regulatory Authority (ZAMRA)Original source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

Memphis Pharmaceutical & Chemical Industries Revenue Breakdown – EGX:MPCI

TradingViewOriginal source

🌍Jul 24Regulatoryzamra.co.zmTier 1 · Regulatory source

Guidelines-on-Application for Clinical Trial Authorisation

Zambia Medicines Regulatory Authority (ZAMRA)Original source

🌍Jul 24Regulatoryzamra.co.zmTier 1 · Regulatory source

APPLICATION-FOR-GRANT-OF-MARKETING-AUTHORISATION-OF-COSMETICS-FOR-USE-IN-ZAMBIA

Zambia Medicines Regulatory Authority (ZAMRA)Original source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

How Specialty Growth and Cold Chain Demand Are Rewriting Distribution Strategy

Pharmaceutical CommerceOriginal source

🌍Jul 24discoverynews.google.comTier 3 · Aggregated media

The Biotech Growth Trust PLC - Net Asset Value(s)

Yahoo Finance UKOriginal source